MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 23 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $103,000 | -34.4% | 101,703 | +17.9% | 0.00% | – |
| Q3 2016 | $157,000 | +248.9% | 86,253 | +144.1% | 0.00% | – |
| Q2 2016 | $45,000 | -36.6% | 35,340 | +167.1% | 0.00% | – |
| Q1 2016 | $71,000 | -33.0% | 13,232 | -4.5% | 0.00% | – |
| Q4 2015 | $106,000 | +3.9% | 13,850 | +13.4% | 0.00% | – |
| Q3 2015 | $102,000 | – | 12,218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |